| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |